Note 14 - Loss Per Share

3 Months Ended

Dec. 31, 2023

Notes to Financial Statements

Earnings Per Share [Text Block]

NOTE 14 – LOSS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share for the following periods:

	Three Months Ended
	December 31,			December 31,
	2023			2022
Basic and diluted:
Net loss continuing operations	$	(996,501	)	$	(3,956,062	)
Preferred dividends paid		1,000,501			1,000,502
Net loss attributable to cbdMD Inc. common shareholders		(1,997,002	)		(4,956,564	)
Shares used in computing basic and diluted earnings per share		2,960,945			1,341,277
Loss per share Basic:
Basic and diluted earnings per share		(0.67	)		(3.70	)

At December 31, 2023, 93,113 potential shares underlying options, unvested RSUs and warrants as well as 185,223 convertible preferred shares, as well as total 283,593 of available shares and remaining commitment share under the Keystone agreement were excluded from the shares used to calculate diluted loss per share as their inclusion would reduce net loss per share.